biostudies-literatureMiller CNCATS NIH HHSClinical and Translational Intramural Funding Program from the Abigail Wexner Research InstituteThe Ohio State University’s National Center for Advancing Translational Sciencese0302734https://www.ebi.ac.uk/biostudies/studies/S-EPMC11142545biostudies-literatureUnknown19(5)Since the early 2000's, digital reading applications have enhanced the language and literacy skills of typically hearing young children; however, no digital storybook intervention currently exists to scaffold the early language and literacy skills of their peers who are deaf or hard of hearing. To address this gap, our research team developed a novel digital storybook intervention called Hear Me Read with the aim of enhancing the therapeutic, language, and literacy benefits of speech-language therapy. This prospective clinical trial (registered at clinicaltrials.gov, NCT#: 05245799) aims to determine the efficacy of adding Hear Me Read to in-person speech-language therapy for children aged three to five years who are deaf or hard of hearing. Fifty caregivers, their child, and their child'sPloS oneStudy protocol for Hear Me Read (HMR): A prospective clinical trial assessing a digital storybook intervention for young children who are deaf or hard of hearing.PMC11142545UM1 TR004548AWD00001881UM1TR004548Pattisapu PMiller CMalhotra PBoone KMfalseStudy protocol for Hear Me Read (HMR): A prospective clinical trial assessing a digital storybook intervention for young children who are deaf or hard of hearing.Since the early 2000's, digital reading applications have enhanced the language and literacy skills of typically hearing young children; however, no digital storybook intervention currently exists to scaffold the early language and literacy skills of their peers who are deaf or hard of hearing. To address this gap, our research team developed a novel digital storybook intervention called Hear Me Read with the aim of enhancing the therapeutic, language, and literacy benefits of speech-language therapy. This prospective clinical trial (registered at clinicaltrials.gov, NCT#: 05245799) aims to determine the efficacy of adding Hear Me Read to in-person speech-language therapy for children aged three to five years who are deaf or hard of hearing. Fifty caregivers, their child, and their child's2024-01-01T00:00:00Z20242026-06-02T19:23:37.268Z2026-04-19T03:13:48.848ZS-EPMC111425453882041310.1371/journal.pone.0302734